Rivaroxaban Impurity 135 | CAS 35475-03-7 - Request Quote
Rivaroxaban Impurity 135
| SZ CAT No: | SZ-R017208 |
| CAS No | 35475-03-7 |
| Mol.F. | C6H5ClO2S |
| Mol.Wt. | 176.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 135 is chemically Methyl 5-chlorothiophene-2-carboxylate. Rivaroxaban Impurity 135 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 135 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 35475-03-7
Purchase 35475-03-7
Order 35475-03-7
Enquire 35475-03-7
price of 35475-03-7
35475-03-7 Supplier
35475-03-7 Manufacturer
35475-03-7 Exporter
buy high quality Rivaroxaban Impurity 135
Purchase Rivaroxaban Impurity 135
Rivaroxaban Impurity 135 suppliers
Rivaroxaban Impurity 135 manufacturers
Rivaroxaban Impurity 135 price
Order Rivaroxaban Impurity 135
Enquire Rivaroxaban Impurity 135
Rivaroxaban Impurity 135 cost
Rivaroxaban Impurity 135 Supplier
Rivaroxaban Impurity 135 Distributor
Rivaroxaban Impurity 135 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 135 for ANDA Filing
Rivaroxaban Impurity 135 for Forced Degradation Studies
Rivaroxaban Impurity 135 Identification Standards
Rivaroxaban Impurity 135 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


